This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

HPV

  1. January is cervical health awareness month. As we reflect on global progress in cervical cancer prevention, screening, and treatment, promising new evidence could accelerate progress toward elimination.
    Published: January 2020
    Type: Article
  2. The Single-Dose HPV Vaccine Evaluation Consortium encompasses nine leading independent research institutions working together to collate and synthesize existing evidence and evaluate new data on the potential for single-dose HPV vaccination.
    Published: January 2020
    Type: Resource Page
  3. A synthesis of the white paper on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the evidence; and forthcoming evidence.
    Published: December 2019
    Type: Resource Page
  4. This brief summarizes a comprehensive review and assessment of current, published evidence for a single-dose HPV vaccination schedule. The review was undertaken by researchers in the Single-Dose HPV Vaccine Evaluation Consortium.
    Published: December 2019
    Type: Resource Page
  5. Imagine you need treatment for cervical precancer.
    Published: November 2019
    Type: Article
  6. Global national HPV vaccine introduction maps.
    Published: November 2019
    Type: Resource Page
  7. This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.
    Published: September 2019
    Type: Resource Page
  8. The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.
    Published: June 2019
    Type: Resource Page
  9. Vaccines are one of the most effective global public health interventions ever.
    Published: April 2019
    Type: Article
  10. When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
    Published: March 2019
    Type: Article
Load more